Agreement signedPublished 21 Aug 2026
Werewolf Therapeutics, Inc. /
Ambros Therapeutics, Inc.
Werewolf Therapeutics, Inc. signed an agreement for Ambros Therapeutics, Inc.




01 / BuyerWerewolf Therapeutics, Inc.
02 / TargetAmbros Therapeutics, Inc.
Source for the buyer and target: Werewolf Therapeutics, Inc.
For the buyer and target.
“On August 21, 2026, Werewolf Therapeutics, Inc., a Delaware corporation (“Werewolf”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among Ambros Therapeutics, Inc., a Delaware corporation (“Ambros”), Werewolf, and Wave Atlantis Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Werewolf (“Merger Sub”).”
Published 21 Aug 2026
Open the sourceWhat happened
The deal for Ambros Therapeutics, Inc. is signed, with Werewolf Therapeutics, Inc. as the buyer. [01]
The filing from Werewolf Therapeutics, Inc. is dated Aug. 21, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
01
Source · Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. signed an agreement for Ambros Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly